Company: HURA
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-179009
Chunk: 11

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-12
Form: S-1
Chunk 11
---
 of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our common stock held by non-affiliates equals or exceeds $250 million as of the end of that year’s second fiscal quarter, or (2) our annual revenues equaled or exceeded $100 million during such completed fiscal year and the market value of our common stock held by non-affiliates equals or exceeds $700 million as of the end of that year’s second fiscal quarter.**

<div align='center'>3</div>

The Offering

| Common stock offered by the selling stockholders | Up to 9,518,618 shares of our common stock, par value $0.001 per share, or the Shares, comprising up to (i) 4,759,309 shares of our common stock and (ii) 4,759,309 shares of our common stock issuable upon the exercise of warrants. |

| Shares of common stock outstanding before this offering | 50,046,926 shares as of August 11, 2025. |

| Terms of the offering | The selling stockholders will determine when and how to sell the common stock offered in this prospectus, as described in “Plan of Distribution.” |

| Use of proceeds | We will not receive any proceeds from the sale of shares being sold by the selling stockholders. We will, however, receive proceeds on the exercise by the selling stockholders of outstanding warrants for shares of our common stock covered by this prospectus if the warrants are exercised for cash. See “Use of Proceeds.” |

| Nasdaq Capital Market Symbol | “HURA”. |

| Risk factors | Investing in our common stock involves a high degree of risk. See “Risk Factors” beginning on page 5 of this prospectus for a discussion of factors you should carefully consider before investing in our common stock. |

The number of shares of common stock to be outstanding after the Offering is based on 50,046,926 shares of common stock outstanding at August 11, 2025 (assuming exercise by the selling stockholders of all warrants being offering), excludes the following as of August 11, 2025:

| • |     | 6,488,116 shares of common stock issuable upon the exercise of stock options outstanding at a weighted exercise price of $5.13 per share; |

| • |     |